JANET SCHOLLE: Open Payments
NPI 1124076302 · WPB, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 22 payments from 9 companies in 2025. Trend: 2023 $693 · 2024 $463 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $322 |
| Neurocrine BioSciences, Inc. | 4 | $135 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lundbeck LLC | 1 | $22 |
| Almatica Pharma LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, INGREZZA, REXULTI, LOREEV XR, Auvelity, AUSTEDO XR, TMS NeuroHealth Centers Inc., Jornay PM.
Industry payments across FL — which companies pay providers there.
